Publications by authors named "Zsofia Dombi"

Claim this Profile
E
Editorial: Women with neuropsychiatric disorders: understanding & personalizing needs.
Ágota Barabássy, Zsófia Borbála Dombi, Kristina Gemzell-Danielsson, Maria Judit Molnar

Front Psychiatry· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing measurement-based care through triangle of care: Development and feasibility of the Transdiagnostic Global Impression - Psychopathology scale for patients and informants - ADDENDUM.
Roger S McIntyre, Zsofia Borbala Dombi, Agota Barabassy, Thomas Brevig, György Németh

Eur Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia.
Sofia Pappa, Réka Csehi, Ellice Caldwell-Dunn, Zsófia Borbála Dombi, Stephan Hjorth

Int J Neuropsychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing measurement-based care through triangle of care: Development and feasibility of the Transdiagnostic Global Impression - Psychopathology scale for patients and informants.
Roger S McIntyre, Zsofia Borbala Dombi, Agota Barabassy, Thomas Brevig, György Németh

Eur Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdiagnostic Efficacy of Cariprazine: A Systematic Review and Meta-Analysis of Efficacy Across Ten Symptom Domains.
Agota Barabassy, Réka Csehi, Zsófia Borbála Dombi, Balázs Szatmári, Thomas Brevig

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice.
Christoph U Correll, Zsófia B Dombi, Ágota Barabássy, György Németh, Thomas Brevig

Eur Neuropsychopharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring.
Máté Szabó, Zoltán Hujber, Judit Harsányi, Balázs Szatmári, Zsófia B Dombi

Clin Pharmacokinet· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the latent state-trait structure of the PANSS in cariprazine-medicated and placebo-controlled patients with acute schizophrenia.
Jana S Krückl, Károly Acsai, Zsófia B Dombi, Julian Moeller, Roselind Lieb

Eur Arch Psychiatry Clin Neurosci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine.
Viktória Meszár, Gabriella Magyar, Gabriella Mészárosné Pásztor, Balázs Szatmári, Krisztina Péter, Zsófia B Dombi

Pharmacopsychiatry· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of patients with predominant negative symptoms in Slovakia: A 1-year longitudinal, prospective, multicentric cohort study.
Jozef Dragasek, Zsofia Borbala Dombi, Károly Acsai, Viktor Dzurilla, Ágota Barabássy

Eur Psychiatry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside.
Ágota Barabássy, Zsófia Borbála Dombi, György Németh

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone.
Stefan Leucht, Zsófia Borbála Dombi, Péter Szabó, Ágota Barabássy, Stephen Z Levine

Schizophr Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II.
Peter Falkai, Zsófia Borbála Dombi

Front Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials.
Peter Falkai, Zsófia B Dombi, Károly Acsai, Ágota Barabássy, Andrea Schmitt

CNS Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing negative symptoms of schizophrenia pharmacologically with cariprazine: evidence from clinical trials, a real-world study, and clinical cases.
György Németh, Zsófia B Dombi, István Laszlovszky, Ágota Barabássy

Expert Opin Pharmacother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis.
Zsófia B Dombi, István Szendi, Philip W J Burnet

Front Psychiatry· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies.
Réka Csehi, Zsófia Borbála Dombi, Barbara Sebe, Mária Judit Molnár

Front Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia.
Elmars Rancans, Zsófia Borbála Dombi, Ágota Barabássy

Front Psychiatry· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of caring for someone with schizophrenia: A cross country report from Bulgaria, the Czech Republic, Hungary and Russia.
Sebe Barbara, Ágota Barabássy, Krisztina Buksa, István Laszlovszky, Zsófia Borbála Dombi

Psychiatr Hung· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study.
Elmars Rancans, Zsófia Borbála Dombi, Péter Mátrai, Ágota Barabássy, Barbara Sebe

Int Clin Psychopharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and early complications of preterm infants with birthweight less than 500 grams during a 10-year period in Hungary.
Péter Varga, Botond Berecz, Zsófia Magyar, Barbara Pete, Éva Romicsné Görbe, Zsófia Anna Dombi

Paediatr Perinat Epidemiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality trends in very-very low birth weight premature infants in light of recent changes in obstetric care.
Péter Varga, Botond Berecz, Ákos Gasparics, Zsófia Dombi, Zsuzsa Varga

Eur J Obstet Gynecol Reprod Biol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis